Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.
Saved in:
| Title: | Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies. |
|---|---|
| Authors: | Sasi BK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Martindale S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Civanelli E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Shupe SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Machado JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Ren Y; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Lahn M; iOnctura SA; Geneva., Van der Veen L; iOnctura BV; Amsterdam, Netherlands., Di Conza G; iOnctura SA; Geneva., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale; Bellinzona. francesco.bertoni@ior.usi.ch., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts, USA; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Boston, MA. jennifer_brown@dfci.harvard.edu. |
| Source: | Haematologica [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 2974-2985. Date of Electronic Publication: 2025 Jun 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40534489 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sasi+BK%22">Sasi BK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tarantelli+C%22">Tarantelli C</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Martindale+S%22">Martindale S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Civanelli+E%22">Civanelli E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Cannas+E%22">Cannas E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Sartori+G%22">Sartori G</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Arribas+AJ%22">Arribas AJ</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Fernandes+SM%22">Fernandes SM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Shupe+SJ%22">Shupe SJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Machado+JH%22">Machado JH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tyekucheva+S%22">Tyekucheva S</searchLink>; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ren+Y%22">Ren Y</searchLink>; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lahn+M%22">Lahn M</searchLink>; iOnctura SA; Geneva.<br /><searchLink fieldCode="AU" term="%22Van+der+Veen+L%22">Van der Veen L</searchLink>; iOnctura BV; Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Di+Conza+G%22">Di Conza G</searchLink>; iOnctura SA; Geneva.<br /><searchLink fieldCode="AU" term="%22Bertoni+F%22">Bertoni F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale; Bellinzona. francesco.bertoni@ior.usi.ch.<br /><searchLink fieldCode="AU" term="%22Brown+JR%22">Brown JR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts, USA; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Boston, MA. jennifer&#95;brown@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 2974-2985. <i>Date of Electronic Publication: </i>2025 Jun 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40534489 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3324/haematol.2024.287180 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2974 Titles: – TitleFull: Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sasi BK – PersonEntity: Name: NameFull: Tarantelli C – PersonEntity: Name: NameFull: Martindale S – PersonEntity: Name: NameFull: Civanelli E – PersonEntity: Name: NameFull: Cannas E – PersonEntity: Name: NameFull: Sartori G – PersonEntity: Name: NameFull: Arribas AJ – PersonEntity: Name: NameFull: Fernandes SM – PersonEntity: Name: NameFull: Shupe SJ – PersonEntity: Name: NameFull: Machado JH – PersonEntity: Name: NameFull: Tyekucheva S – PersonEntity: Name: NameFull: Ren Y – PersonEntity: Name: NameFull: Lahn M – PersonEntity: Name: NameFull: Van der Veen L – PersonEntity: Name: NameFull: Di Conza G – PersonEntity: Name: NameFull: Bertoni F – PersonEntity: Name: NameFull: Brown JR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1592-8721 Numbering: – Type: volume Value: 110 – Type: issue Value: 12 Titles: – TitleFull: Haematologica Type: main |
| ResultId | 1 |